These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14524299)

  • 1. [Efficacy and safety of inhaled drugs].
    Alkiewicz J
    Pol Merkur Lekarski; 2003 Jun; 14(84):668-71. PubMed ID: 14524299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective inhaled drug administration to mechanically ventilated patients.
    Dhand R; Mercier E
    Expert Opin Drug Deliv; 2007 Jan; 4(1):47-61. PubMed ID: 17184162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids.
    Hübner M; Hochhaus G; Derendorf H
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):469-88. PubMed ID: 16054538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New horizons in respiratory care: the pharmacology of inhaled aerosol drug therapy.
    Fink JB; Rau JL
    Respir Care; 2000 Jul; 45(7):824-5. PubMed ID: 10926378
    [No Abstract]   [Full Text] [Related]  

  • 5. New frontiers in aerosol delivery during mechanical ventilation.
    Dhand R
    Respir Care; 2004 Jun; 49(6):666-77. PubMed ID: 15165301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic treatment by inhalation of macromolecules--principles, problems, and examples.
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():53-79. PubMed ID: 19218633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance therapy with anti-inflammatory antiasthmatic drugs: inhaled corticosteroids and leukotriene receptor antagonists.
    Riccioni G; Bucciarelli T; Mancini B; Di Ilio E; Palumbo G; D'Orazio N
    Clin Ter; 2007; 158(4):363-70. PubMed ID: 17953289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
    Onoue S; Misaka S; Kawabata Y; Yamada S
    Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of halogen aerosol therapy on resistance parameters of the respiratory tract].
    Chervinskaia AV; Kvetnaia AS; Cherniaev AL; Apul'tsina ID; Amelina EL; Molodtsova VP; Faustova ME
    Ter Arkh; 2002; 74(3):48-52. PubMed ID: 11980122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():11-8. PubMed ID: 15688664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental macromolecular aerosol therapy.
    Rubin BK
    Respir Care; 2000 Jun; 45(6):684-94. PubMed ID: 10894461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ProSeal LMA for surfactant administration.
    Micaglio M; Zanardo V; Ori C; Parotto M; Doglioni N; Trevisanuto D
    Paediatr Anaesth; 2008 Jan; 18(1):91-2. PubMed ID: 18095983
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of MAS with PPHN using combined therapy: SLL, bolus surfactant and iNO.
    Gadzinowski J; Kowalska K; Vidyasagar D
    J Perinatol; 2008 Dec; 28 Suppl 3():S56-66. PubMed ID: 19057612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ambroxol].
    Akkoca Yildiz O
    Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs used in respiratory therapy.
    Sladen A
    Clin Anesth; 1974; 10(1):315-41. PubMed ID: 4598997
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postdeposition dispersion of aerosol medications using surfactant carriers.
    Marcinkowski AL; Garoff S; Tilton RD; Pilewski JM; Corcoran TE
    J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):361-70. PubMed ID: 18800882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosol therapy: regimen and device compliance in daily practice.
    Everard ML
    Paediatr Respir Rev; 2006; 7 Suppl 1():S80-2. PubMed ID: 16798605
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dosage aerosols; problems with the inhalation technic].
    Baas AA; Hekking PJ; Schaap C
    Ned Tijdschr Geneeskd; 1989 Aug; 133(32):1606-8. PubMed ID: 2797267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.